WoS Publication

WoS Publication RDF

pages:

Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy Article
PET HAS MINIMAL INFLUENCE ON THE DECISION TO PERFORM INVASIVE MONITORING PRIOR TO TEMPORAL LOBECTOMY Article
PET Stress Testing with Coronary Flow Capacity in the Evaluation of Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Rethinking the Current Paradigm Article
Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment Article
Phaeohyphomycosis Infections in Solid Organ Transplant Recipients - The Largest Single Institution Experience Article
Pharmaco-Immunomodulatory Therapy in COVID-19 Article
Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice Article
Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review Article
Phase 2 open-label, dose-finding study of intravenous ganaxolone for the treatment of refractory status epilepticus Article
Phase 2, randomized, double-blind, placebo-controlled multi- center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia Article
PHASE I CANCER CLINICAL TRIAL FOR 4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE (DM-CHOC-PEN) Article
Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia Article
Phase Ib clinical study of CBP501, cisplatin and nivolumab administered every 3 weeks in patients with advanced refractory tumors. Dose escalation cohort Article
Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every three weeks in patients with advanced refractory tumors: Efficacy in dose-escalation and expansion cohorts. Article
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma Article
Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS. Article
Phase II clinical trial: Safety and efficacy study of tocilizumab (Toci) in combination with ipilimumab (Ipi) 3mg/kg plus nivolumab (Nivo) 1mg/kg in patients (pts) with metastatic melanoma (MM) Article
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma Article
Phenotype and mutation expansion of the PTPN23 associated disorder characterized by neurodevelopmental delay and structural brain abnormalities Article
PHENOTYPE AND OUTCOMES OF ACUTE KIDNEY INJURY ASSOCIATED WITH COVID-19 (Withdrawn Publication. See vol. 69, pg. 947, 2021) (Withdrawn Publication. See vol. 69, pg. 947, 2021) Article
Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations Article
Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants Article
Phenytoin and Other Hydantoins Book
PHEOCHROMOCYTOMA OF THE ORGAN OF ZUCKERLANDL Article
Phoma Infections: Classification, Potential Food Sources, and Their Clinical Impact Article
Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments Article
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status Article
Physical Activity and Cardiorespiratory Fitness as Modulators of Health Outcomes: A Compelling Research-Based Case Presented to the Medical Community Article
Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality Article
Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults Article

pages: